Can Stem Cell-Delivered Platelets Fight Drug-Resistant Bacteria?- RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Qirui Lin et al:
“Can Stem Cell-Delivered Platelets Fight Drug-Resistant Bacteria?
MRSA infections remain a serious clinical challenge in the era of multidrug resistance.
Platelets are known to have antibacterial properties — but the mechanisms are incompletely understood, and whether induced pluripotent stem cell-derived platelets (iPSC-PLTs) share this capacity had never been tested.
A new study in RPTH Journal investigated the MRSA-killing potential of iPSC-PLTs and the mechanisms involved.
Key findings:
- All 3 iPSC-PLT clones demonstrated MRSA-killing capacity in vitro
- MyD88-deficient iPSC-PLTs showed impaired killing
- MRSA α-toxin (Hla) suppressed iPSC-PLT bactericidal function
iPSC-PLTs offer a unique advantage:
They are gene-editable, making them a powerful platform for investigating platelet antimicrobial function, and potentially a novel therapeutic tool against resistant infections.”
Title: Induced pluripotent stem cell-derived platelets kill multidrug-resistant Staphylococcus aureus via Toll-like receptor 2-MyD88 signaling and immunoglobulin G/FcyRIIA engagement
Authors: Qirui Lin, Kimiko Nonomura, Ieva Stirblyte, Sou Nakamura, Satoshi Uchiyama, Masaya Yamaguchi, Shigetada Kawabata, Miki Nagao, Katsue Suzuki-Inoue, Victor Nizet, Koji Eto, Naoshi Sugimoto
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 23, 2026, 14:00Ron Vezina: Canadian Blood Services Issues Urgent Donation Appeal
-
Jul 23, 2026, 13:46Sebastian Szmit: Understanding Troponins in Modern Cardio-Oncology
-
Jul 23, 2026, 13:41Colleen Grady: Why Normal Hemoglobin Does Not Exclude Iron Deficiency
-
Jul 23, 2026, 13:22Jacob Kelly: AHA Review Highlights Coffee’s Cardiovascular Benefits
-
Jul 23, 2026, 13:01Sally Mandour: Automated Blood Indices Enhance IDA Diagnosis in Cirrhotic Patients
-
Jul 23, 2026, 12:42Eva Pavlidou: A Memorable First ISTH Experience
-
Jul 23, 2026, 10:33Johanna Rodríguez: The Structural Challenge of Next-Gen Anticoagulants
-
Jul 23, 2026, 10:27Logan Hamilton: New Study Identifies the Mutated Antibody Gene Responsible for VITT
-
Jul 23, 2026, 09:05Fonkou Steve: What If We’ve Been Asking the Wrong Question About Plasma Too?